OSIMPLANT Chooses Invibio’s Polymer for Cervical Disc Implant

OSIMPLANT has selected Invibio Biomaterial Solutions’ MOTIS polymer for its CE marked ARAMIS cervical disc prosthesis.

Advertisement

The MOTIS polymer was chosen for its mechanical strength, creep resistance and wear performance. Designed to minimize patient pain and combat spinal degenerative diseases such as spondylosis and herniated nucleus pulposus, ARAMIS relies on MOTIS’ performance properties to advance patient and surgeon benefits.

More Articles on Orthopedic Devices:

FDA Recalls GE’s Spinal Navigation System

Orchid Medical Acquires WIN’s Surgical Implant Business

Investors Sue Internal Fixation Systems Over Alleged Misinformation

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.